假冒医疗产品：尼泊尔处于脆弱地位。
Counterfeit Healthcare Products: Nepal at a Vulnerable Position.
机构信息
Drug and Patient Safety Unit, Lumbini Provincial Hospital, Rupandehi, Nepal.
出版信息
JNMA J Nepal Med Assoc. 2022 Dec 1;60(256):1070-1072. doi: 10.31729/jnma.7684.
UNLABELLED
Nepal stands in a vulnerable position when it comes to counterfeit medicines as two of its major trade partners countries are leading producers of falsified healthcare products. The impacts that it can lead to are a lower standard of healthcare delivery to the public, increased cost of treatment, antibiotic resistance, and even fatality. The time of crisis as the Coronavirus disease 2019 pandemic is often seen as an opportunity to endorse substandard products in greater amounts. The people's doubt over the medicine is another issue generated by this malpractice that can lead to problems like vaccine hesitancy which can have scary outcomes so forth in a pandemic situation like this. Stronger national policies and vigilant authorities are prime to overcoming flourishing counterfeit culture as it is a peak time when we can not put public health at stake.
KEYWORDS
counterfeit medicines; Nepal; patient safety; substandard medicines.
未加标签
尼泊尔在假冒药品方面处于脆弱地位，因为其两个主要贸易伙伴国家是伪造医疗保健产品的主要生产国。这可能导致的影响是向公众提供的医疗服务标准降低、治疗费用增加、抗生素耐药性，甚至死亡。随着 2019 年冠状病毒病大流行，危机时期经常被视为更多地认可劣质产品的机会。由于这种不当行为，人们对药品的怀疑是另一个产生的问题，这可能导致疫苗犹豫等问题，在这种大流行情况下会产生可怕的后果。加强国家政策和警惕的主管部门是克服假冒文化盛行的关键，因为这是我们不能危及公众健康的关键时刻。
关键词
假冒药品；尼泊尔；患者安全；劣质药品。
Zotero 插件